Due to coronavirus, grocery stores have been inundated with demands on their supply chains. As such, various strengths and weaknesses of countries' readiness for a new pandemic have been exposed.
One flow-on consideration in the United States has caused them to re-evaluate their emergency reserve on medicine. How is Australia's medicine manufacturing and distribution structured?
We chatted with Elizabeth De Somer the CEO of Medicines Australia about all things pharmaceutical.
For info on general medicines shortages, please visit here
Live content
false
Editorial Approval